Skip to main content
XNCR logo

XNCR · Xencor Inc · Executive Compensation

Track XNCR — free
$35.40 -1.69 (-4.56%) At close · Nov 16 Q4 2023 earnings call transcript
Market Cap
$2.66B
Shares
75.04M
Volume · Nov 16 1.03M Avg daily vol (3M) 1.55M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Dr. Bassil I. Dahiyat $5,521,205
John Desjarlais $1,982,252
Bart Jan Cornelissen $1,642,396
Celia E. Eckert $1,570,479
Nancy Valente $430,766
Fiscal 2024
Executive Total
Dr. Bassil I. Dahiyat $6,811,829
John Kuch $4,287,528
Bart Jan Cornelissen $3,731,011
Nancy Valente $2,867,773
John Desjarlais $2,827,992
Celia E. Eckert $1,971,889
Fiscal 2023
Executive Total
Dr. Bassil I. Dahiyat $7,965,955
Nancy Valente $5,168,862
John Desjarlais $3,213,094
Allen S. Yang $2,944,364
John Kuch $2,233,493
Celia E. Eckert $2,021,919
Fiscal 2022
Executive Total
Dr. Bassil I. Dahiyat $7,705,952
John Desjarlais $2,955,047
Allen S. Yang $2,810,649
John Kuch $2,114,941
Celia E. Eckert $1,892,680
Fiscal 2021
Executive Total
Dr. Bassil I. Dahiyat $5,370,295
John Desjarlais $2,625,325
Allen S. Yang $2,437,276
John Kuch $1,745,969
Celia E. Eckert $1,698,869
Fiscal 2020
Executive Total
Dr. Bassil I. Dahiyat $4,480,925
John Desjarlais $1,870,907
John Kuch $1,504,141
Celia E. Eckert $999,728
Allen S. Yang $678,932

Executive changes

Person Change Filed
Raymond J. Deshaies Appointed 2025-07-31
Todd Simpson Appointed 2025-05-07
Nancy Valente Resigned 2025-05-07
Todd Simpson Appointed 2025-03-13
Bart Cornelissen Appointed 2024-04-09
John Kuch Retired 2023-10-26
Barbara Klencke, M.D. Appointed 2023-09-19
Dr. Allen Yang Terminated 2023-07-03
Allen Yang Resigned 2023-04-26
Nancy Valente Appointed 2023-04-26
Nancy Valente Resigned 2023-04-26
Nancy Valente Appointed 2022-09-09
Yujiro S. Hata Resigned 2022-09-09

Leadership

Key facts CIK 1326732 CUSIP 98401F105 13F (30d) 205 filings 189 filers Visit website Investor relations